During the past decade, Intermountain Healthcare conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 3 clinical trials were completed, i.e. on average, 27.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Intermountain Healthcare" #1 sponsor was "CardioDx" with 2 trials, followed by "Intermountain Health Care, Inc." with 2 trials sponsored, "University of Utah" with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Agency for Healthcare Research and Quality (AHRQ)" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Intermountain Healthcare" #1 collaborator was "Intermountain Health Care, Inc." with 4 trials as a collaborator, "Johns Hopkins University" with 2 trials as a collaborator, "Medical University of South Carolina" with 2 trials as a collaborator, "University of Utah" with 2 trials as a collaborator and "Arrowhead Regional Medical Center" with 1 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 83 trials.

According to Clinical.Site data, the most researched conditions in "Intermountain Healthcare" are "CVD" (2 trials), "Cardiovascular Diseases" (2 trials), "Coronary Artery Disease" (2 trials), "Acute-graft-versus-host Disease" (1 trials) and "Advanced Solid Tumors" (1 trials). Many other conditions were trialed in "Intermountain Healthcare" in a lesser frequency.

Most popular intervention types in "Intermountain Healthcare" are "Drug" (7 trials), "Other" (6 trials), "Behavioral" (2 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Abemaciclib" (1 trials), "Amonafide and Cytarabine" (1 trials), "Anti-hypertensive therapy" (1 trials) and "Atezolizumab and PHESGO" (1 trials). Other intervention names were less common.

The vast majority of trials in "Intermountain Healthcare" are 14 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Intermountain Healthcare". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Intermountain Healthcare, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Intermountain Healthcare, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".